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A 66-year-old woman was referred to our hospital with a right renal tumor in October 2010. In 1984,
she underwent a mastectomy because of left breast cancer. In 2006, she underwent a lobectomy because of
right lung cancer. A follow-up computed tomography of the lung cancer revealed a right renal tumor which
extended to the right quadratus lumborum muscle. An exploratory laparotomy was performed and the
tumor was found to be malignant by an intra-operative examination. Then, we performed a right radical
nephrectomy together with the excision of quadratus lumborum muscle. Pathological examination revealed
breast cancer metastasized to the pararenal fat. We could not ﬁnd any invasion of the tumor into the renal
parenchyma. We followed her for 2 months after the operation without any evidence of recurrence, but she
suddenly expired due to an unrelated accident.
(Hinyokika Kiyo 59 : 113-116, 2013)


















tiated adenocarcinoma mixed type，pT2N1M0，stage IIb
であった．術後補助化学療法としてパクリタキセル
(85 mg/body，day 1，8，15），カルボプラチン (550
mg/body，day 1) 投与を 4クール施行した．2010年10
月，肺癌のフォローアップ CT で，右腎腫瘍を認め，
当科紹介受診となった．
入院時現症 : 身長 150 cm，体重 39 kg，血圧 130/85
mmHg，脈拍60回/分，体温 37.0°C，身体所見に特記
事項なし．
入院時検査所見 : 末梢血液像 : WBC 4,510/μ l，
RBC 404万/μl，Hb 12.3 g/dl，Ht 36.5％，Plt 17.0万/
μl と軽度血小板低下を認めた．
血液生化学検査 : Alb 4.5 g/dl，T-Bil 0.6 mg/dl，
AST 25 U/l，ALT 10 U/l，CK 110 U/l，Cr 0.59 mg/
dl，Na 138 mEq/l，K 3.9 mEq/l，Cl 101 mEq/l，Glu
234 mg/dl と血糖高値を認めた．
腫瘍マーカー : CEA 1.8 ng/ml，CA19-9 12 U/ml，
SCC 0.9 ng/ml，NSE 11.4 ng/ml，CYFRA 5.2 ng/ml
(≤2.8) と CYFRA 高値を認めた．
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尿所見 : 蛋白（−），糖（2＋），RBC 0∼1/HPF，
WBC 0∼1/HPF で自然尿細胞診は陰性であった．
画像所見 : 腹部造影 CT にて，実質相にて造影効果
が弱く，後腎傍腔を超え，背部筋肉近傍まで連続する
33×22 mm 大の腫瘤性病変を認めた (Fig. 1）．腫瘤は
腹部単純 MRI にて T1 強調画像で腎実質と同程度の
低信号，T2 強調画像で腎実質よりも低信号を示し
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Fig. 2. MRI scan. (A) T1-weighted axial image
shows a right renal tumor with low intensity
signal as well as renal parenchyma (arrows).
(B) T2-weighted axial image shows a right
renal tumor with lower intensity signal than
renal parenchyma (arrows).
























Fig. 3. The pathological diagnosis of the tumor was
metastasis of breast cancer (arrow). (A) HE
stain, low power ﬁeld (×40). (B) HE stain,
high power ﬁeld (×400).
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Fig. 4. The pathological diagnosis of the lung tumor
was adenocarcinoma (arrow) ; HE stain,






estrogen receptor α（クローン : 1D5)（以下 : ERα) で




























免疫染色に関して，自験例では ERα と TTF を使用
した．ERα は乳癌や婦人科癌で陽性になることが多
いが，肺癌でも一部陽性を示し6,7)，そのクローンが
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